FMR1 (Fragile X Mental Retardation 1), located on chromosome Xq27.3, encodes an RNA-binding protein that regulates translation at synapses and is essential for normal cognitive development. Expansion of a CGG trinucleotide repeat in the 5' UTR of FMR1 causes Fragile X Syndrome (FXS), the most common inherited cause of intellectual disability and a leading cause of autism. Premutation alleles (55-200 CGG repeats) can cause Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in older adults.
The FMR1 gene encodes FMRP (Fragile X Mental Retardation Protein), a 632-amino acid RNA-binding protein:
- Translational regulation: Represses translation of target mRNAs at synapses
- Synaptic plasticity: Regulates mGluR-dependent long-term depression (LTD)
- Dendritic spine development: Essential for normal spine morphology
- RNA transport: Transports mRNAs to dendritic processes
- DNA damage response: FMRP involved in DNA repair pathways
- Neuronal development: Critical for cortical circuit formation
FMRP contains multiple RNA-binding domains: two KH domains and an RGG box. It associates with translation initiation machinery and polysomes to regulate protein synthesis.
| Feature |
Details |
| Molecular weight |
~71 kDa |
| Domains |
N-terminal, KH1 (140-234), KH2 (258-349), RGG (513-571) |
| Isoforms |
Multiple isoforms from alternative splicing |
| Post-translation |
Phosphorylation, ubiquitination, methylation |
| Crystal structure |
KH domains: PDB: 2QND, 2QNE |
- Inheritance: X-linked dominant; full mutation (>200 CGG repeats)
- Normal repeat: 5-44 CGG repeats
- Premutation: 55-200 CGG repeats
- Mechanism: CGG expansion causes promoter hypermethylation and FMR1 silencing
- Intellectual disability (IQ 40-85)
- Developmental delay
- Language impairment
- Social anxiety and autism features
- Hyperactivity and attention deficits
- Seizures (30%)
- Long face, large ears, macroorchidism
- Connective tissue abnormalities
| Disorder |
Features |
Repeat Size |
| FXTAS |
Tremor, ataxia, dementia |
55-200 |
| FXPOI |
Premature ovarian insufficiency |
55-200 |
| FMR1-related autism |
Social deficits |
55-200 |
- Alzheimer's disease: FMRP changes observed in AD brain
- Parkinson's disease: Possible interaction with alpha-synuclein
- Huntington's disease: FMRP dysregulation in HD models
- Brain: High in cortex, hippocampus, cerebellum, thalamus
- Cell types: Neurons (especially pyramidal neurons), astrocytes
- Subcellular: Cytoplasmic; associated with polysomes; dendritic localization
- Regulation: Developmental regulation; activity-dependent
- Allen Brain Atlas: High expression in pyramidal neurons throughout cortex
- Verkerk et al., Identification of FMR1 gene (1991)
- Bakker et al., FMR1 knockout mouse model (1994)
- Huberman et al., FMRP and synaptic plasticity (2006)
- Darnell and Darnell, FMRP function in translation (2011)
- Hagerman et al., FXTAS: clinical features (2005)
- Berry-Kravis et al., Fragile X syndrome clinical trials (2020)
- Mientjes et al., FMR1 brain expression (2006)
- Suhl and Warren, Single-molecule studies of FMRP (2015)
- mGluR5 antagonists: Mavoglurant, fenobam
- GABA agonists: Arbaclofen
- Antagonists of过剩 glutamate signaling
- ASO therapy: FMR1 reactivation strategies
- Gene editing: CRISPR approaches to reduce repeat
- FMRP restoration
- Synaptic function normalization
- Translation regulation correction
- Behavioral interventions